Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

166
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
166
Errors In Hypothesis Tests01:14

Errors In Hypothesis Tests

4.1K
When performing a hypothesis test, there are four possible outcomes depending on the actual truth (or falseness) of the null hypothesis and the decision to reject or not.
4.1K
Bonferroni Test01:10

Bonferroni Test

2.7K
The Bonferroni test is a statistical test named after Carlo Emilio Bonferroni, an Italian mathematician best known for Bonferroni inequalities. This statistical test is a type of multiple comparison test to determine which means are different than the rest. Bonferroni test can minimize the Type 1 error by reducing the significance level alpha, which otherwise increases with sample pairs.
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
2.7K
Blinding01:11

Blinding

2.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.3K
Blind Procedures02:07

Blind Procedures

10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Contaminants and Errors01:16

Contaminants and Errors

81
Effective sample preparation is crucial for accurate and reliable laboratory analysis. During this process, two significant sources of error can arise: concentration bias from improper sample splitting and contamination caused by methods used to reduce particle size, such as grinding or homogenization. Identifying and minimizing these potential errors is crucial to ensuring the validity of the analysis.
Another key consideration is determining the appropriate number of samples required to...
81

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluating a Tailored Web-Based eHealth Intervention for Symptom Management in Couples Managing Prostate Cancer During the COVID-19 Pandemic: Randomized Clinical Trial.

Journal of medical Internet research·2026
Same author

The Univariate Distribution of Hierarchical Composite Endpoints and the Condorcet Non-transitivity Paradox.

Biometrical journal. Biometrische Zeitschrift·2026
Same author

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Canopy2: Tumor Phylogeny Inference by Bulk DNA and Single-Cell RNA Sequencing.

Statistics in biosciences·2026
Same author

Association between Participant Characteristics and Breast Parenchymal Texture Variation among Postmenopausal Women.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

Author Correction: AIM2 in regulatory T cells restrains autoimmune diseases.

Nature·2025

相关实验视频

Updated: May 22, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

在部分解盲样本大小重新估计时保存I型错误.

Ann Marie K Weideman1,2, Kevin J Anstrom1,2, Gary G Koch1

  • 1Department of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Statistics in medicine
|March 14, 2025
PubMed
概括

本研究引入了一种在临床试验中进行样本大小重新估计 (SSR) 的新型部分不盲目的方法. 这种方法保持了I型错误率,同时允许基于二进制和连续结果的中间数据进行调整.

关键词:
适应性设计是适应性的设计.进行中期分析分析.调整样本大小的调整.保存I型错误的保护方法不平等待遇分配不平等的待遇分配变量异质性的异质性

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.4K
Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

3.8K

相关实验视频

Last Updated: May 22, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.4K
Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

3.8K

科学领域:

  • 生物统计学 生物统计学
  • 临床试验设计 临床试验设计
  • 统计学方法论 统计学方法论

背景情况:

  • 样本大小重新估计 (SSR) 对于适应性临床试验至关重要,可以根据累计数据进行调整.
  • 目前的SSR方法采用盲定或非盲定方法,旨在保持I型错误率.
  • 需要SSR方法来平衡运营可行性和统计严谨性.

研究的目的:

  • 提出和评估在临床试验中重新估计样本大小 (SSR) 的部分不盲目的方法.
  • 评估该方法对二进制和连续端点的I型错误率的影响.
  • 在各种变异场景下探索和澄清SSR的数学表达式,包括双变异.

主要方法:

  • 开发了一种部分解盲的SSR方法,使用没有效果大小的临时数据来保持操作盲目.
  • 进行了概念验证和模拟研究,以验证该方法的性能.
  • 研究了SSR对二进制和连续数据的同质性,异质性和双变异场景的数学表达式.

主要成果:

  • 拟议的部分解盲SSR方法有效地保持了I型错误率.
  • 证明了该方法对二进制和连续终点的适用性.
  • 衍生和澄清SSR的双方方差数学表达式,表明它们提供了同质性和异质性之间的妥协,有界样本大小估计,以及适应性设计的适合性.

结论:

  • 部分解盲的SSR提供了适应性试验设计的可行策略,保持统计完整性.
  • 开发的方法在样本大小调整方面提供了灵活性,而不会影响I型错误率.
  • 这些发现扩大了SSR方法的实用性,特别是双变异方法,用于更广泛的临床试验设计.